Extracted from this filing and checked against the source text.
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.95
AMGEN INC entered into Term Loan Credit Agreement with Citibank, N.A., Bank of America, N.A., Goldman Sachs Bank USA, Mizuho Bank, Ltd. valued at $4,000,000,000 term loan credit facility with two tranches: $2,000,000,000 18-month and $2,000,000,0 (effective 2022-12-22).
- Action
- entry
- Agreement
- credit facility
- Counterparty
- Citibank, N.A., Bank of America, N.A., Goldman Sachs Bank USA, Mizuho Bank, Ltd.
- Value
- $4,000,000,000 term loan credit facility with two tranches: $2,000,000,000 18-month and $2,000,000,0
- Effective
- 2022-12-22
Exact text from the filing
Term Loan Credit Facility On December 22, 2022 (the “ Effective Date ”), Amgen Inc. (“ Amgen ”), Citibank, N.A. (“ Citibank ”), as administrative agent, Bank of America, N.A. (“ Bank of America ”), as syndication agent, Citibank, Bank of America, Goldman Sachs Bank USA and Mizuho Bank, Ltd. as lead arrangers and book runners, and Goldman Sachs Bank USA and Mizuho Bank, Ltd. as documentation agents entered into a Term Loan Credit Agreement (the “ Term Loan Credit Agreement ”). The Term Loan Credit Agreement provides for a (1) a $2,000,000,000 18-month term loan tranche (the “ 18-Month Tranche ”) and (2) a $2,000,000,000 3-year term loan tranche (the “ 3-Year Tranche ”, and together with the 18-Month Tranche, the “ Term Loan Credit Facility ”), with the commitments under the Bridge Credit Agreement entered into by Amgen, as borrower, Citibank, as administrative agent, Bank of America, as syndication agent, and Citibank and Bank of America as lead arrangers and book runners, on December 1
View on SEC.gov